Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 14/20 | 0.56 |
| ▸ | CDK2 | P24941 | 5/20 | 0.52 |
| ▸ | CDK1 | P06493 | 1/20 | 0.52 |
| ▸ | CDK9 | P50750 | 1/20 | 0.52 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.52 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.47 |
| ▸ | CCNE1 | P24864 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13305565 | 0.89 | GSK3B (0.58) | GSK3BCDK2CDK1CDK9CDK5 | |
| SCHEMBL13305593 | 0.87 | GSK3B (0.55) | GSK3BCDK2CDK1CDK9CDK5 | |
| SCHEMBL14582522 | 0.87 | GSK3B (0.74) | GSK3BCDK2CCNE1 | |
| SCHEMBL14347821 | 0.87 | GSK3B (0.74) | GSK3BCDK2CCNE1 | |
| SCHEMBL12952853 | 0.87 | GSK3B (0.74) | GSK3BCDK2CCNE1 | |
| SCHEMBL13305560 | 0.81 | GSK3B (0.65) | GSK3BCDK2CHEK1CCNE1 | |
| SCHEMBL14347823 | 0.80 | GSK3B (0.71) | GSK3BCDK2CDK1CDK9CDK5 | |
| SCHEMBL13305608 | 0.80 | CDK2 (0.52) | GSK3BCDK2CDK1CDK9CDK5 | |
| SCHEMBL12954066 | 0.80 | GSK3B (0.61) | GSK3BCDK2CHEK1CCNE1 | |
| SCHEMBL13304782 | 0.78 | GSK3B (0.72) | GSK3BCDK2CCNE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1537116-B1 | PYRAZOLOPYRIMIDINES SUITABLE FOR THE TREATMENT OF CANCER DISEASES | SCHERING CORP (US) | 2010-06-02 | — | — | EP | disclosed |